Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.68 USD | -0.83% | +1.69% | -12.72% |
May. 10 | Bristol-Myers Squibb Says Phase 3 Trial of Opdivo in Lung Cancer Fails to Meet Primary Endpoint | MT |
May. 10 | Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint | DJ |
Filters
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company